Literature DB >> 14760945

Oligoclonal bands in Devic's neuromyelitis optica and multiple sclerosis: differences in repeated cerebrospinal fluid examinations.

R Bergamaschi1, S Tonietti, D Franciotta, E Candeloro, E Tavazzi, G Piccolo, A Romani, V Cosi.   

Abstract

We studied repeated cerebrospinal fluids of patients with Devic's neuromyelitis optica (NMO) and multiple sclerosis (MS). Variations of oligoclonal bands (OBs) had opposite trends in the two groups. In MS, OBs were detected in 399 of 411 patients (97%) and never disappeared. In NMO, OBs were detected in three of 11 patients (27%) and always disappeared. The hypothesis that NMO and MS follow distinct pathogenetic pathways is supported by our findings, which can be useful for the differentiation of NMO from MS.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14760945     DOI： 10.1191/1352458504ms988oa

Source DB:  PubMed          Journal:  Mult Scler        ISSN： 1352-4585            Impact factor:   6.312


  22 in total

1.  Treatment of neuromyelitis optica: current debate.

Authors:  Tomoko Okamoto; Masafumi Ogawa; Youwei Lin; Miho Murata; Sachiko Miyake; Takashi Yamamura
Journal:  Ther Adv Neurol Disord       Date:  2008-07       Impact factor: 6.570

2.  [Noninflammatory pathogenesis of lesions in multiple sclerosis].

Authors:  M E Kornhuber
Journal:  Nervenarzt       Date:  2006-08       Impact factor: 1.214

3.  [Diagnosis and treatment of neuromyelitis optica. Consensus recommendations of the Neuromyelitis Optica Study Group].

Authors:  C Trebst; A Berthele; S Jarius; T Kümpfel; S Schippling; B Wildemann; C Wilke
Journal:  Nervenarzt       Date:  2011-06       Impact factor: 1.214

Review 4.  Demyelinating diseases.

Authors:  S Love
Journal:  J Clin Pathol       Date:  2006-11       Impact factor: 3.411

5.  Differential diagnosis of suspected multiple sclerosis: a consensus approach.

Authors:  D H Miller; B G Weinshenker; M Filippi; B L Banwell; J A Cohen; M S Freedman; S L Galetta; M Hutchinson; R T Johnson; L Kappos; J Kira; F D Lublin; H F McFarland; X Montalban; H Panitch; J R Richert; S C Reingold; C H Polman
Journal:  Mult Scler       Date:  2008-09-19       Impact factor: 6.312

6.  A patient with a benign course of neuromyelitis optica (Devic's syndrome) over 12 years: MRI follow up and histological findings.

Authors:  H Köller; E Neuen-Jacob; A Saleh; B C Kieseier; S Jander; H-P Hartung
Journal:  J Neurol       Date:  2006-03-06       Impact factor: 4.849

7.  Relapsing Devic's disease in a child.

Authors:  Gokcen Gokce; Osman M Ceylan; Fatih M Mutlu; Halil I Altinsoy; Talay Koylu
Journal:  J Pediatr Neurosci       Date:  2013-05

Review 8.  [Neuromyelitis optica].

Authors:  S Jarius; B Wildemann
Journal:  Nervenarzt       Date:  2007-12       Impact factor: 1.214

9.  MRI criteria in MS patients with negative and positive oligoclonal bands: equal fulfillment of Barkhof's criteria but different lesion patterns.

Authors:  Hagen B Huttner; Peter D Schellinger; Tobias Struffert; Gregor Richter; Tobias Engelhorn; Teresa Bassemir; Mathias Mäurer; Meritxell Garcia; Stefan Schwab; Martin Köhrmann; Arnd Doerfler
Journal:  J Neurol       Date:  2009-03-01       Impact factor: 4.849

10.  Consensus Guidelines for CSF and Blood Biobanking for CNS Biomarker Studies.

Authors:  Charlotte E Teunissen; Hayrettin Tumani; Jeffrey L Bennett; Frode S Berven; Lou Brundin; Manuel Comabella; Diego Franciotta; Jette L Federiksen; John O Fleming; Roberto Furlan; Rogier Q Hintzen; Steve G Hughes; Connie R Jimenez; Michael H Johnson; Joep Killestein; Eva Krasulova; Jens Kuhle; Maria-Chiara Magnone; Axel Petzold; Cecilia Rajda; Konrad Rejdak; Hollie K Schmidt; Vincent van Pesch; Emmanuelle Waubant; Christian Wolf; Florian Deisenhammer; Gavin Giovannoni; Bernhard Hemmer
Journal:  Mult Scler Int       Date:  2011-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.